Celcuity Inc.
CELC
$116.94
$1.381.19%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
12/3/2025
-
MarketBeat
4/8/2026
-
MarketBeat
4/7/2026
-
Simply Wall St
Celcuity (CELC, $112.68) entered Downtrend as Momentum indicator drops below 0 level on Apr 02, 2026
4/3/2026
-
Tickeron - Stocks
4/3/2026
-
Tickeron - Stocks
4/2/2026
-
MarketBeat
4/1/2026
-
Simply Wall St
4/1/2026
-
Simply Wall St
4/1/2026
-
Tickeron - Stocks
3/31/2026
-
Simply Wall St
3/31/2026
-
Simply Wall St
3/30/2026
-
MarketBeat
3/30/2026
-
MarketBeat
3/30/2026
-
MarketBeat
3/30/2026
-
Simply Wall St
3/30/2026
-
Simply Wall St
3/28/2026
-
MarketBeat
3/27/2026
-
Insider Monkey
3/27/2026
-
Simply Wall St
3/27/2026
-
Simply Wall St
Celcuity (CELC, $114.81) entered Uptrend as Momentum indicator ascends above 0 level on Mar 26, 2026
3/27/2026
-
Tickeron - Technical Analysis
3/27/2026
-
Tickeron - Technical Analysis
3/27/2026
-
TipRanks Financial Blog
3/27/2026
-
Nasdaq News: Markets
3/27/2026
-
Fool.com Headlines
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, March 26, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of May 11 and 15 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
763 392 0767
Address
16305 36th Avenue North
Minneapolis, MN 55446
Minneapolis, MN 55446
Country
Year Founded
Business Description
Sector
Celcuity Inc., a clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company’s lead drug...
more